Manufactures and supplies ophthalmic pharmaceuticals and CE‑marked medical devices for eye-care providers and patients across Egypt, the Middle East and Africa. Holds WHO‑GMP, ISO 9001/14001 and OHSAS certifications; marketed portfolio includes 35 ophthalmic drugs and 3 CE‑marked devices, with a pipeline of about 60 additional ophthalmic formulations.